Gene · 5648
Papers2,041
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,041
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Complement activation in COVID-19 and targeted therapeutic options: A scoping review. | Blood Rev | 2023 | 35934552 | PubTator, text mining | PubMed |
| Hepatocyte-derived MASP1-enriched small extracellular vesicles activate HSCs to promote liver fibrosis. | Hepatology | 2023 | 35849032 | PubTator, text mining | PubMed |
| Lectin Pathway Enzyme MASP-2 and Downstream Complement Activation in COVID-19. | J Innate Immun | 2023 | 35816998 | PubTator, text mining | PubMed |
| Evaluation of C4b as an adjunct marker in symptomatic RT-PCR negative Covid-19 cases. | Indian J Clin Biochem | 2023 | 35756690 | PubTator, text mining | PubMed |
| In-stent Thrombosis and COVID-19 Infection: Current Insights on the Mechanistic Relationship. | Curr Cardiol Rev | 2023 | 35549872 | PubTator, text mining | PubMed |
| Circular RNAs: Biomarkers of cancer. | Cancer Innov | 2022 | 38089761 | PubTator, text mining | PubMed |
| Data-driven Uncertainty Quantification in Computational Human Head Models. | Comput Methods Appl Mech Eng | 2022 | 37994358 | PubTator, text mining | PubMed |
| Dysregulation of complement system in neuropsychiatric disorders: A mini review. | Biomark Neuropsychiatry | 2022 | 37123465 | PubTator, text mining | PubMed |
| New Insights into the Pathogenesis and Treatment Strategies in IgA Nephropathy. | Glomerular Dis | 2022 | 36751267 | PubTator, text mining | PubMed |
| Free complement and complement containing extracellular vesicles as potential biomarkers for neuroinflammatory and neurodegenerative disorders. | Front Immunol | 2022 | 36741417 | PubTator, text mining | PubMed |
| An environmentally relevant concentration of antibiotics impairs the immune system of zebrafish (Danio rerio) and increases susceptibility to virus infection. | Front Immunol | 2022 | 36713462 | PubTator, text mining | PubMed |
| Trypanosoma cruzi-specific CD8+ T cells and other immunological hallmarks in chronic Chagas cardiomyopathy: Two decades of research. | Front Cell Infect Microbiol | 2022 | 36683674 | PubTator, text mining | PubMed |
| Unveiling the Great Therapeutic Potential of MASPs as Hemostatic Agents. | J Hematol | 2022 | 36632573 | PubTator, text mining | PubMed |
Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2-positive breast cancer patients: new findings and a systematic review. | Cancer Drug Resist | 2022 | 36627894 | PubTator, text mining | PubMed |
| Thrombotic microangiopathy mediates poor prognosis among lupus nephritis via complement lectin and alternative pathway activation. | Front Immunol | 2022 | 36582241 | PubTator, text mining | PubMed |
| Association of complement components with the risk and severity of NAFLD: A systematic review and meta-analysis. | Front Immunol | 2022 | 36569882 | PubTator, text mining | PubMed |
| Biological Features of Nanoparticles: Protein Corona Formation and Interaction with the Immune System. | Pharmaceutics | 2022 | 36559099 | PubTator, text mining | PubMed |
| High Performance Marine and Terrestrial Bioadhesives and the Biomedical Applications They Have Inspired. | Molecules | 2022 | 36558114 | PubTator, text mining | PubMed |
| Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients. | Biomolecules | 2022 | 36551272 | PubTator, text mining | PubMed |
| Role of complement activation in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. | Front Med (Lausanne) | 2022 | 36530865 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5648/papers?page=17